Figure 1.

(A) Systolic blood pressure and (B) heart rate for all experimental groups after 4 weeks of treatment with vehicle or resveratrol. DMC-V: Diabetic control group receiving vehicle; Sham-V: Sham-operated receiving vehicle; DM-V: Diabetic receiving vehicle; HTN-V: Hypertensive receiving vehicle; DM+HTN-V: Diabetic hypertensive receiving vehicle; DM+HTN-R5: Diabetic hypertensive receiving 5 mg/kg/day resveratrol; DM+HTN-R10: Diabetic hypertensive receiving 10 mg/kg/day resveratrol; DM+HTN-R20: Diabetic hypertensive receiving 20 mg/kg/day resveratrol; Data are mean±SEM and n=8-10 in each group; *Significant difference (P<0.05) from DMC-V or Sham-V; ∆Significant difference (P<0.05) from DM+HTN-V